ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ)
$10.71 -0.44 (-3.9462%)
Analysed ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) News Sources
Nuvation Bio (NUVB) Soars 7.9%: Is Further Upside Left in the Stock?
21-07-2026
yahoo.com
Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV)
18-06-2026
yahoo.com
Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus
23-06-2026
yahoo.com
Enanta Pharmaceuticals (ENTA) Moves 5.2% Higher: Will This Strength Last?
24-06-2026
yahoo.com
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026
10-08-2026
yahoo.com
Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Lags Revenue Estimates
10-08-2026
yahoo.com
Enanta Pharmaceuticals to Participate in September Investor Conferences
01-09-2026
yahoo.com
Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at IDWeek™ 2026
13-10-2026
yahoo.com
Enanta Pharmaceuticals Announces First Patient Dosed in the RESOLVE Phase 2b/3 Study of Zelicapavir, a Potential First-in-Disease Treatment for Respiratory Syncytial Virus (RSV)
26-10-2026
yahoo.com
Enanta Pharmaceuticals Announces Planned Retirement of Longstanding Chief Executive Officer Jay R. Luly, Ph.D. After 23 Years of Company Leadership
28-10-2026
yahoo.com
What is the current price of ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ)?
The current price of ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) is $10.71.
ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) since the previous trading day is $-0.44.
ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) since the previous trading day is -3.9462%.
What is the most recent average sentiment score for ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ)?
The most recent average sentiment score for ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ)?
The most recent sentiment for ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ) is .
SEC-8K** Filing Available For ENANTA PHARMACEUTICALS INC (ENTA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.